bpc 157 side effects eyes Stable Gastric Pentadecapeptide 157—Possible Novel Therapy of Glaucoma and Other Ocular Conditions The Hidden Risks of BPC‑157:

For women with PCOS and metabolic syndrome, prediabetes, or progressive weight loss resistance, GLP-1 therapy addresses multiple pathological mechanisms simultaneously a meaningful advantage over single-target agents

Because it inhibits bacterial growth, it's safer to use over time than regular sterile water

The peptide's molecular weight of 340 Da allows excellent skin penetration when applied topically, though systemic administration provides broader therapeutic effects

Interstitial fibrosis and a decreased capillary network leading to a decreased blood supply and hypoxia are correlated with declining renal function